Green light for bivalent booster


green light new law approval
First bivalent COVID-19 vaccine approved for use in Australia The TGA has provisionally approved Moderna's Spikevax bivalent COVID-19 vaccine for use as a booster dose in adults 18 years and over. It is the first bivalent COVID-19 vaccine approved for use in Australia. The Spikevax Bivalent Original/Omicron vaccine contains 25 micrograms of imelasomeran that targets

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Section 150 advice
Next The debate continues